Waterloo pharmacist examines drug therapies for Alzheimer’s disease
As Alzheimer’s disease continues to impact more and more Canadians, the need for novel therapies and therapeutic drugs is greater than ever. Using a state-of-the-art technology to discover new therapies to treat Alzheimer’s disease is among the projects receiving funding from the Canada Foundation for Innovation (CFI), announced today.